CN103908537A - Traditional Chinese medicine for treating herpes zoster - Google Patents

Traditional Chinese medicine for treating herpes zoster Download PDF

Info

Publication number
CN103908537A
CN103908537A CN201410133542.6A CN201410133542A CN103908537A CN 103908537 A CN103908537 A CN 103908537A CN 201410133542 A CN201410133542 A CN 201410133542A CN 103908537 A CN103908537 A CN 103908537A
Authority
CN
China
Prior art keywords
parts
chinese medicine
radix
herpes zoster
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410133542.6A
Other languages
Chinese (zh)
Inventor
李燕
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410133542.6A priority Critical patent/CN103908537A/en
Publication of CN103908537A publication Critical patent/CN103908537A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine for treating herpes zoster. The traditional Chinese medicine is prepared from the following raw materials in parts by weight: 30-40 parts of radix paeoniae alba, 15-25 parts of fructus aurantii, 20-30 parts of root of red-rooted salvia, 20-30 parts of scutellaria baicalensis, 10-16 parts of rheum officinale, 6-13 parts of akebiaquinata, 5-9 parts of rhizoma alismatis, and 7-13 parts of jasmine. The traditional Chinese medicine for treating the herpes zoster takes the radix paeoniae alba as the primary drug, and is assorted with other auxiliary drugs to affect with one another and play a synergistic effect, so as to play good roles of clearing away heat and toxic materials, promoting blood circulation to remove blood stasis and relieving swelling and pain. The traditional Chinese medicine has a good curative effect on herpes zoster, and is simple in raw material, low in cost and convenient to take.

Description

A kind of Chinese medicine for the treatment of herpes zoster
(1) technical field:
The present invention relates to technical field of Chinese medicines, specifically a kind of Chinese medicine for the treatment of herpes zoster.
(2) background technology:
Herpes zoster is the actute infection dermatoses being caused by varicella zoster virus.After infected without the child of immunity to this virus, there is chickenpox.After some patients were is infected, become carrier and symptom does not occur.Because virus has neurotropism, after infection, can hide for a long time in the neuron of spinal nerves posterior root ganglion, in the time of lower for the resistance or tired, infection, flu, virus can regrow breeding, and move to skin along nerve fiber, make nerve and the skin of being invaded produce strong inflammation.The feature that erythra generally has one-sided property and distributes by nerve segment, is made up of the herpes of collection bunch property, and with pain; Age is larger, and neuralgia is heavier.Primary disease is apt to occur in adult, and season in spring and autumn is common.Sickness rate increased and is remarkable rising with the age.The Chinese medicine of this type of disease for the treatment of is a lot of at present, for example publication number is CN102085284A, name is called the Chinese invention patent application of " a kind of Chinese medicine for the treatment of herpes zoster ", a kind of Chinese medicine for the treatment of herpes zoster is disclosed, it is made up of the component of the material medicine proportioning of following weight, the Radix Astragali 8~12g, Radix Panacis Quinquefolii 8~10g, the Rhizoma Atractylodis Macrocephalae 8~15g, Radix Angelicae Sinensis 8~12g, Rhizoma Dioscoreae 8~12g, Semen euryales 6~10g, Cortex Phellodendri 10~15g, Radix Sophorae Flavescentis 10~14g, the Radix Rehmanniae 8~10g, each 6~the 10g of Radix Arnebiae (Radix Lithospermi), Radix Paeoniae Rubra 8~10g, Radix Salviae Miltiorrhizae 6~8g, Caulis Spatholobi 6~8g, each 6~the 10g of Sanguis Draxonis, Borneolum Syntheticum 3~6g.Traditional Chinese medicine of the present invention is simple, and at the bottom of cost, medicine source is wide, easy to use, curative effect is fast, and cure rate is high, without any side effects.Through clinical application for many years checking, can effectively treat herpes zoster, comprise the herpes zoster of delay property, effective percentage 100%, cure rate is more than 92%.But this medicine material pharmacopoeia class is too many, compatibility complexity.
(3) summary of the invention:
The technical problem to be solved in the present invention is to provide the Chinese medicine of the treatment herpes zoster that a kind of compatibility is simple, preventive effect good, safety has no side effect.
For addressing the above problem, the present invention adopts following technical proposals:
The present invention treats the Chinese medicine of herpes zoster, is to be made up of the raw material of following weight proportioning:
The Radix Paeoniae Alba 30~40, Fructus Aurantii 15~25, Radix Salviae Miltiorrhizae 20~30, Radix Scutellariae 20~30, Radix Et Rhizoma Rhei 10~16, Caulis Akebiae 6~13, Rhizoma Alismatis 5~9, Fructus Gardeniae 7~13.
The preferred weight proportioning of each raw material is:
The Radix Paeoniae Alba 32~38, Fructus Aurantii 18~22, Radix Salviae Miltiorrhizae 22~28, Radix Scutellariae 22~28, Radix Et Rhizoma Rhei 12~15, Caulis Akebiae 8~12, Rhizoma Alismatis 6~8, Fructus Gardeniae 8~12.
The optimum weight proportioning of each raw material is:
The Radix Paeoniae Alba 35, Fructus Aurantii 20, Radix Salviae Miltiorrhizae 25, Radix Scutellariae 25, Radix Et Rhizoma Rhei 13, Caulis Akebiae 10, Rhizoma Alismatis 7, Fructus Gardeniae 10.
The preparation method that the present invention treats the Chinese medicine of herpes zoster is: take by weight ratio the raw material Radix Paeoniae Alba, Fructus Aurantii, Radix Salviae Miltiorrhizae, Radix Scutellariae, Radix Et Rhizoma Rhei, Caulis Akebiae, Rhizoma Alismatis, Fructus Gardeniae, add the decocting of 5~8 times of raw material weights to boil, after water boils, slow fire boils 30~40 minutes, leaches medicinal liquid, to obtain final product.
The instructions of taking that the present invention treats the Chinese medicine of herpes zoster is: oral, every day twice, each serving 150~200 grams.
The present invention treats the Chinese medicine of herpes zoster taking the Radix Paeoniae Alba as principal agent, other accessory drugs of arranging in pairs or groups, and they influence each other, synergism, thereby play good heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain effect, herpes zoster is had to good curative effect, and its raw material is simple, with low cost, taking convenience.
(4) detailed description of the invention:
With embodiment, the invention will be further described below, but the present invention is not limited to these embodiment.
Umber described in following embodiment is weight portion.
Embodiment 1
Drug weight proportioning:
30 parts of the Radix Paeoniae Albas, 15 parts of Fructus Aurantiis, 20 parts of Radix Salviae Miltiorrhizaes, 20 parts of Radix Scutellariaes, 10 parts of Radix Et Rhizoma Rhei, 6 parts of Caulis Akebiaes, 5 parts of Rhizoma Alismatis, 7 parts of Fructus Gardeniaes.
Preparation method:
Take raw material by above-mentioned weight proportion, add the decocting of 5 times of raw material weights to boil, after water boils, slow fire boils 30 minutes, leaches medicinal liquid, to obtain final product.
Embodiment 2
Drug weight proportioning:
40 parts of the Radix Paeoniae Albas, 25 parts of Fructus Aurantiis, 30 parts of Radix Salviae Miltiorrhizaes, 30 parts of Radix Scutellariaes, 16 parts of Radix Et Rhizoma Rhei, 13 parts of Caulis Akebiaes, 9 parts of Rhizoma Alismatis, 13 parts of Fructus Gardeniaes.
Preparation method:
Take raw material by above-mentioned weight proportion, add the decocting of 8 times of raw material weights to boil, after water boils, slow fire boils 40 minutes, leaches medicinal liquid, to obtain final product.
Embodiment 3
Drug weight proportioning:
35 parts of the Radix Paeoniae Albas, 20 parts of Fructus Aurantiis, 25 parts of Radix Salviae Miltiorrhizaes, 25 parts of Radix Scutellariaes, 13 parts of Radix Et Rhizoma Rhei, 10 parts of Caulis Akebiaes, 7 parts of Rhizoma Alismatis, 10 parts of Fructus Gardeniaes.
Preparation method:
Take raw material by above-mentioned weight proportion, add the decocting of 7 times of raw material weights to boil, after water boils, slow fire boils 40 minutes, leaches medicinal liquid, to obtain final product.
Experimental example:
Below example is further set forth the present invention and treats the beneficial effect of the Chinese medicine of herpes zoster by experiment.
1, experiment crowd:
Be divided into A, two experimental grouies of B:
A group: patient's 68 examples; Wherein male 40 examples, female's 28 examples, 15~30 years old age.
B group: patient's 80 examples; Wherein male 30 examples, female's 50 examples, 30~45 years old age.
2, drug administration method:
Chinese medicine every day of the treatment herpes zoster that the oral embodiment of the present invention 3 makes 2 times, each serving 200 grams, serve on 7 days.
3, efficacy evaluation:
(1) invalid: compared with before taking medicine, without significant change.
(2) effective: therapeutic effect is obvious.
4, therapeutic effect:

Claims (3)

1. treat a Chinese medicine for herpes zoster, it is characterized in that being made by the raw material of following weight proportioning:
The Radix Paeoniae Alba 30~40, Fructus Aurantii 15~25, Radix Salviae Miltiorrhizae 20~30, Radix Scutellariae 20~30, Radix Et Rhizoma Rhei 10~16, Caulis Akebiae 6~13, Rhizoma Alismatis 5~9, Fructus Gardeniae 7~13.
2. the Chinese medicine for the treatment of herpes zoster according to claim 1, is characterized in that the weight proportion of each raw material is:
The Radix Paeoniae Alba 32~38, Fructus Aurantii 18~22, Radix Salviae Miltiorrhizae 22~28, Radix Scutellariae 22~28, Radix Et Rhizoma Rhei 12~15, Caulis Akebiae 8~12, Rhizoma Alismatis 6~8, Fructus Gardeniae 8~12.
3. the Chinese medicine for the treatment of herpes zoster according to claim 2, is characterized in that the weight proportion of each raw material is:
The Radix Paeoniae Alba 35, Fructus Aurantii 20, Radix Salviae Miltiorrhizae 25, Radix Scutellariae 25, Radix Et Rhizoma Rhei 13, Caulis Akebiae 10, Rhizoma Alismatis 7, Fructus Gardeniae 10.
CN201410133542.6A 2014-03-31 2014-03-31 Traditional Chinese medicine for treating herpes zoster Pending CN103908537A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410133542.6A CN103908537A (en) 2014-03-31 2014-03-31 Traditional Chinese medicine for treating herpes zoster

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410133542.6A CN103908537A (en) 2014-03-31 2014-03-31 Traditional Chinese medicine for treating herpes zoster

Publications (1)

Publication Number Publication Date
CN103908537A true CN103908537A (en) 2014-07-09

Family

ID=51034741

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410133542.6A Pending CN103908537A (en) 2014-03-31 2014-03-31 Traditional Chinese medicine for treating herpes zoster

Country Status (1)

Country Link
CN (1) CN103908537A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105311417A (en) * 2015-12-02 2016-02-10 卢雨萍 Externally applied traditional Chinese medicine for treating herpes zoster

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1836715A (en) * 2005-03-26 2006-09-27 李有凤 External use medicine for quickly treating herpes zoster
CN101721564A (en) * 2008-10-30 2010-06-09 宋修芳 Traditional Chinese medicine for treating shingles
CN101732462A (en) * 2009-11-11 2010-06-16 宋爱民 Chinese medicinal preparation for treating herpes zoster
CN102423464A (en) * 2011-12-07 2012-04-25 卢军亚 Medicine for treating herpes zoster

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1836715A (en) * 2005-03-26 2006-09-27 李有凤 External use medicine for quickly treating herpes zoster
CN101721564A (en) * 2008-10-30 2010-06-09 宋修芳 Traditional Chinese medicine for treating shingles
CN101732462A (en) * 2009-11-11 2010-06-16 宋爱民 Chinese medicinal preparation for treating herpes zoster
CN102423464A (en) * 2011-12-07 2012-04-25 卢军亚 Medicine for treating herpes zoster

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105311417A (en) * 2015-12-02 2016-02-10 卢雨萍 Externally applied traditional Chinese medicine for treating herpes zoster

Similar Documents

Publication Publication Date Title
CN103933468A (en) Traditional Chinese medicine for treating acute pancreatitis
CN103393966B (en) A kind of Chinese medicine composition for the treatment of menoxenia
CN104547666A (en) Traditional Chinese medicine composition for treating herpes zoster
CN103263522A (en) Traditional Chinese medicine for treating parotitis
CN103705782A (en) Traditional Chinese medicine composition for treating herpes zoster
CN104042761A (en) Traditional Chinese medicine (TCM) composition for treating herpes zoster
CN103585591A (en) Traditional Chinese medicine for treating gallstones
CN102225118B (en) Blood-activating wind-dispelling liquid
CN103908556A (en) Traditional Chinese medicine for treating varicella
CN103893502A (en) Traditional Chinese medicine for treating phlyctenular conjunctivitis
CN103845620A (en) Traditional Chinese medicine for treating raynaud disease
CN103908537A (en) Traditional Chinese medicine for treating herpes zoster
CN106511813A (en) Drug for treating duck virus hepatitis
CN104162043A (en) Traditional Chinese medicine used for treatment of allergic nodular cutaneous vasculitis
CN104399042A (en) Traditional Chinese medicine for treating intractable diaphragmatic muscle spasm and preparation method thereof
CN104491072A (en) Traditional Chinese medicine for treating nerve-root type cervical spondylosis
CN104189392A (en) Traditional Chinese medicinal composition for treating skin itch and preparation method thereof
CN104606408A (en) Traditional Chinese medicine composition treating orthopedics diseases
CN103479952A (en) Summer-heat relieving soup
CN103816257B (en) A kind of Chinese medicine preparation for the treatment of poliomyelitis
CN104306625A (en) Traditional Chinese medicine used for treating herpes zoster
CN1899401B (en) Three ingredient body comfort liquid
CN104096136A (en) Traditional Chinese medicine for treating chronic pancreatitis
CN104352756A (en) Traditional Chinese medicine composition for treating hyperosteogeny
CN103263516B (en) Medicine for treating cholecystitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140709